Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Retained Earnings Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Retained Earnings
-$938m
CAGR 3-Years
-9%
CAGR 5-Years
-15%
CAGR 10-Years
-16%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Retained Earnings
-CA$7.6m
CAGR 3-Years
-168%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Retained Earnings
-$409.1m
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Repare Therapeutics Inc
NASDAQ:RPTX
Retained Earnings
-$333.1m
CAGR 3-Years
-48%
CAGR 5-Years
-71%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Retained Earnings
-CA$36.3m
CAGR 3-Years
8%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Spectral Medical Inc
TSX:EDT
Retained Earnings
-CA$142.6m
CAGR 3-Years
-15%
CAGR 5-Years
-13%
CAGR 10-Years
-12%

See Also

What is Aurinia Pharmaceuticals Inc's Retained Earnings?
Retained Earnings
-938m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Retained Earnings amounts to -938m USD.

What is Aurinia Pharmaceuticals Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
-16%

Over the last year, the Retained Earnings growth was -2%. The average annual Retained Earnings growth rates for Aurinia Pharmaceuticals Inc have been -9% over the past three years , -15% over the past five years , and -16% over the past ten years .

Back to Top